Bioretec

Bioresorbable orthopaedic implants: the RemeOs™ line of magnesium-alloy and hybrid-composite screws and pins is absorbed and replaced by bone, removing the need for a second removal operation. RemeOs trauma screw is the first and so far only bioresorbable metal implant authorised by the FDA (De Novo, 3/2023); FDA Breakthrough Device Designation for RemeOs DrillPin 12/2025. Founded 1998 (ex-BCI Bioabsorbable Concepts) on Tampere biomaterials research; products in ~40 countries.

The row

Sector

Medtech & Digital Health

Stage

In market — Product is being sold

Location

Tampere

Founded

1998

Research origin

Tampere Univ.

Business ID

1474196-9 · Finnish trade register

Links

Where this sits on the map

Bioretec is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗